Proportion of NAFLD patients with normal ALT value in overall NAFLD patients: a systematic review and meta-analysis

Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis

(2019) Jie Li et al.   Lancet Gastroenterology & Hepatology

PNPLA3 rs738409 is associated with renal glomerular and tubular injury in NAFLD patients with persistently normal ALT levels

(2019) Dan‐Qin Sun et al.   LIVER INTERNATIONAL

The Relationship Between Liver Enzymes and Insulin Resistance in Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease

(2018) Xia Sheng et al.   HORMONE AND METABOLIC RESEARCH

Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030

(2018) Chris Estes et al.   JOURNAL OF HEPATOLOGY

Nonalcoholic fatty liver disease with elevated alanine aminotransferase levels is negatively associated with bone mineral density: Cross-sectional study in U.S. adults

(2018) Toshihiro Umehara   PLoS One

New trends on obesity and NAFLD in Asia

(2017) Jian-Gao Fan et al.   JOURNAL OF HEPATOLOGY

Diagnostic accuracy of serum alanine aminotransferase as biomarker for nonalcoholic fatty liver disease and insulin resistance in healthy subjects, using 3T MR spectroscopy

(2017) Jose Luis Martin-Rodriguez et al.   MEDICINE

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

(2017) Zobair Younossi et al.   Nature Reviews Gastroenterology & Hepatology

Nonalcoholic fatty liver disease: Evolving paradigms

(2017) Amedeo Lonardo et al.   WORLD JOURNAL OF GASTROENTEROLOGY

The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease

(2014) Maryann Maximos et al.   HEPATOLOGY

Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?

(2013) Stuart McPherson et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD)

(2013) Siddharth Verma et al.   LIVER INTERNATIONAL

Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease

(2013) Melania Gaggini et al.   Nutrients

The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

(2012) Naga Chalasani et al.   HEPATOLOGY

Comparison of clinical characteristics of combined hepatocellular-cholangiocarcinoma and other primary liver cancers

(2012) Chern-Horng Lee et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

The role of insulin-sensitizing agents in the treatment of nonalcoholic steatohepatitis

(2011) Lisa B. Van Wagner et al.   Therapeutic Advances in Gastroenterology

Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications

(2009) Elisa Fabbrini et al.   HEPATOLOGY

Non-alcoholic steatohepatitis with normal aminotransferase values

(2009) Hüseyin Saadettin Uslusoy et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels

(2008) V. W.-S. WONG et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes

(2008) Anna Ludovica Fracanzani et al.   HEPATOLOGY

Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease

(2008) W. Ray Kim et al.   HEPATOLOGY